Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Positive European opinion for use of Enbrel in psoriasis

Aug. 3, 2004

Preliminary 30-month data show benefit of Raptiva in psoriasis

Aug. 2, 2004

Neurokinin 1 receptor antagonist effective against postoperative fibrous adhesions

July 30, 2004

PediaMed and Allergan enter pediatrics copromotion agreement for Tazorac

July 30, 2004

FDA approval for Metvix

July 30, 2004

Fully human anti-ICAM antibody effective in murine psoriasis model

July 23, 2004

Enrollment completed for Fibrostat phase IIb study

July 22, 2004

Promising vitamin D analogue for the treatment of psoriasis

July 21, 2004

FDA Advisory Committee recommends against approval of oral tazarotene

July 16, 2004

Studies highlight pimecrolimus efficacy in children with atopic dermatitis

July 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.